Final PMA decisions for July 2004

Aug 11, 2004

Each month the U.S. Food and Drug Administration's Center for Devices and Radiological Health (CDRH) releases a final list of premarket approvals (PMA), product development protocols (PDP), supplement and notice decisions from the previous month. The following decisions were rendered for July 2004:

http://www.fda.gov/cdrh/pma/pmajul04.html

Latest in Regulatory
Ame 2018 12 11 00 02 7009 Atom Nuclear Lab 400
MITA urges 'one stability, one facility' with PET drug inspections
October 4, 2024
Fda
FDA approves flurpiridaz F-18 PET tracer for imaging heart disease
September 27, 2024
Washington Dc Capitol Social
ACR responds to Congressional query on AI reimbursement
May 9, 2024
Question
FDA defines 'transparency' for AI medical devices
February 1, 2024
Related Stories
2004 01 16 16 36 14 706
Regulatory
State x-ray quality assurance program yields dividends
2001 11 16 10 13 24 706
Regulatory
New year brings new coding and bundling changes
Green Pix
Regulatory
Quality Mammography Standards - Delay of Effective Date
More in Regulatory
MITA urges 'one stability, one facility' with PET drug inspections
By AuntMinnie.com staff writers
The Medical Imaging and Technology Alliance (MITA) has responded to the U.S. FDA's change in policy on radiopharmaceutical manufacturer inspections.
October 4, 2024
Ame 2018 12 11 00 02 7009 Atom Nuclear Lab 400
FDA approves flurpiridaz F-18 PET tracer for imaging heart disease
By Will Morton
The U.S. Food and Drug Administration (FDA) approved the radiotracer flurpiridaz F-18 September 27 for PET imaging of coronary artery disease.
September 27, 2024
Fda
ACR responds to Congressional query on AI reimbursement
By Liz Carey
ACR CEO William Thorwarth Jr., MD, issued a nine-page letter to Congress on how to solve the reimbursement problem for AI in healthcare.
May 9, 2024
Washington Dc Capitol Social
FDA defines 'transparency' for AI medical devices
By Will Morton
The U.S. Food and Drug Administration (FDA) has sketched out details to help improve the transparency of AI software product information.
February 1, 2024
Question
MITA members find new home for imaging equipment advocacy efforts
By Erik L. Ridley
Key corporate members and staff from the Medical Imaging Technology Alliance (MITA) are launching a new medical imaging technology division at medical technology trade association Advanced Medical Technology Association (AdvaMed).
December 11, 2023
Business Man Handshake 400
NEA focuses on medical isotope supply chain
By AuntMinnie.com staff writers
Medical radioisotopes are supplied by an aging nuclear infrastructure that threatens the security and availability of critical isotopes.
December 6, 2023
Isotopes
Clarius lauds Fla. bill on ultrasound guidance for plastic surgery
By AuntMinnie.com staff writers
Clarius Mobile Health is applauding the passing of a Florida bill that mandates ultrasound guidance during gluteal fat grafting procedures by plastic surgeons.
July 19, 2023
2021 04 27 22 34 6203 Ultrasound Probe2 400
MITA unveils educational video on OEMs, ISOs
By AuntMinnie.com staff writers
The Medical Imaging and Technology Alliance (MITA) has launched a new educational video that addresses differences in training requirements between original equipment manufacturers (OEMs) and independent service organizations (ISOs).
July 17, 2023
2021 05 04 17 40 9512 Computer Doctor 400
Week in Review: Radiology payment cuts | AI spots diabetes on chest x-rays | SalaryScan
By Erik L. Ridley
July 14, 2023
CMS proposes radiology reimbursement cuts, AUC pause for 2024 MPFS
By Erik L. Ridley
In what has seemingly become an annual event, the U.S. Centers for Medicare and Medicaid Services (CMS) has once again included radiology reimbursement cuts in its Medicare Physician Fee Schedule (MPFS) Proposed Rule.
July 13, 2023
2019 07 31 17 01 7432 Medicare Puzzle 400
FDA: Paclitaxel-coated devices unlikely to increase mortality
By AuntMinnie.com staff writers
The U.S. Food and Drug Administration has sent a letter to healthcare providers stating that use of paclitaxel-coated devices such as balloons and stents in patients with peripheral arterial disease (PAD) is unlikely to increase risk of mortality.
July 10, 2023
2016 09 02 09 36 05 93 Fda Logo V2 400
SNMMI calls for clarity over Leqembi PET scans
By AuntMinnie.com staff writers
The Society of Nuclear Medicine and Molecular Imagine (SNMMI) has called for clarity over whether amyloid PET scans will be covered for potential candidates for the new Alzheimer's disease drug Leqembi (lecanemab).
July 10, 2023
2021 11 20 00 07 5698 Amyloid Plaque Alzheimer2 400
Page 1 of 300
Next Page